Clinical trial
Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated…
NCT00031746 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00031746 |
|---|---|
| Title | Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels |
| Official title | Effects of Dietary Soy on Biomarkers of Prostate Cancer: A Prospective Phase II Study |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | soy protein isolate, casein proteins |
| Enrollment | 26 |
| Start date | Feb 1, 2000 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 19, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: